Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase I trial evaluating administration of STI 9167 at single doses via the IV and IN routes in healthy normal adults or asymptomatic Omicron infected patients

Next Previous
Trial Profile

A phase I trial evaluating administration of STI 9167 at single doses via the IV and IN routes in healthy normal adults or asymptomatic Omicron infected patients

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 05 May 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs STI 9167 (Primary) ; STI 9167 (Primary)
  • Indications COVID 2019 infections
  • Focus Adverse reactions

Most Recent Events

  • 02 May 2022 According to a Sorrento Therapeutics media release, the Phase I safety and pharmacokinetic study in 24 healthy volunteers has completed enrollment.
  • 02 May 2022 Status changed from planning to recruiting, According to a Sorrento Therapeutics media release.
  • 25 Apr 2022 According to a Sorrento Therapeutics media release, FDA granted IND clearance today for STI-9167 (Intravenous COVISHIELD) for a Phase 1 safety and pharmacokinetic study in healthy volunteers.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top